Cronos Group Inc CRON
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CRON is a good fit for your portfolio.
News
-
Cannabis stocks rally after report that DEA will reclassify drug as less dangerous
-
Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders
-
Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024
-
Aurora leads Canadian cannabis stocks higher after pot trade group beefs up ranks with industry exec
-
Cronos Launches Lord Jones® Chocolate Fusions
-
Cronos Group Inc. to Speak at the 36th Annual Roth Conference
-
Toronto Stocks Advance; Canadian Imperial Bank of Commerce Up on 1Q Profit, Revenue Rise
-
Cronos Group Reports 2023 Fourth Quarter and Full-Year Results¹
Trading Information
- Previous Close Price
- CAD 3.66
- Day Range
- CAD 3.62–3.77
- 52-Week Range
- CAD 2.15–4.09
- Bid/Ask
- CAD 3.63 / CAD 3.70
- Market Cap
- CAD 1.39 Bil
- Volume/Avg
- 229,815 / 253,416
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 11.77
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 356
- Website
- https://www.thecronosgroup.com
Competitors
Valuation
|
Metric
|
CRON
|
TLRY
|
ACB
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 0.95 | 0.48 | 0.82 |
Price/Sales | 11.77 | 2.02 | 1.19 |
Price/Cash Flow | — | — | — |
Price/Earnings
CRON
TLRY
ACB
Financial Strength
|
Metric
|
CRON
|
TLRY
|
ACB
|
|---|---|---|---|
Quick Ratio | 21.68 | 0.96 | 1.79 |
Current Ratio | 22.54 | 1.92 | 3.79 |
Interest Coverage | — | −4.39 | — |
Quick Ratio
CRON
TLRY
ACB
Profitability
|
Metric
|
CRON
|
TLRY
|
ACB
|
|---|---|---|---|
Return on Assets (Normalized) | −0.53% | −1.42% | — |
Return on Equity (Normalized) | −0.55% | −1.82% | — |
Return on Invested Capital (Normalized) | −4.90% | −0.92% | — |
Return on Assets
CRON
TLRY
ACB
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Rmjfgmyy | Dmr | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Rzsthvzckl | Mkzgwk | $70.9 Bil | |
HLN
| Haleon PLC ADR | Vjhqjczw | Lgspd | $37.8 Bil | |
VTRS
| Viatris Inc | Krmpjlf | Cwz | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Srmbcbp | Gzyd | $12.7 Bil | |
CTLT
| Catalent Inc | Ggrvxfh | Wnmlxc | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Tjgmwknl | Qlbx | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Yrkrkpvm | Qbbnq | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Qqvrqjpcs | Dzlmv | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Tchyvxqjqc | Xhxz | $3.1 Bil |